{"nct_id":"NCT00622388","title":"Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant","status":"COMPLETED","status_verified_date":"2015-01","start_date":"2007-12","start_date_type":null,"primary_completion_date":"2010-05","primary_completion_date_type":"ACTUAL","completion_date":"2014-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}